MARKET

AKESF

AKESF

Akeso
OTCPK
12.00
NaN%
Closed 09:30 07/24 EDT
OPEN
--
PREV CLOSE
12.00
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
22.70
52 WEEK LOW
10.50
MARKET CAP
11.05B
P/E (TTM)
-68.0658
1D
5D
1M
3M
1Y
5Y
1D
Summit updates survival data for Akeso-partnered lung cancer drug
Seeking Alpha · 2d ago
Akeso Shareholders Approve All Resolutions at 2026 AGM, Renewing Board Mandates and Capital Powers
TipRanks · 06/29 13:40
Akeso, Inc. (9926) Gets a Buy from Soochow Securities
TipRanks · 06/17 05:58
Guotai Haitong Remains a Buy on Akeso, Inc. (9926)
TipRanks · 06/13 05:06
UBS Reaffirms Their Buy Rating on Akeso, Inc. (9926)
TipRanks · 06/13 00:27
Akeso Wins China NMPA Approval for IL-17 Antibody Gumokimab in Psoriasis
TipRanks · 06/12 09:46
Akeso Launches HK$200 Million Share Purchase as Leadership Boosts Stakes
TipRanks · 06/11 04:07
Guotai Haitong Keeps Their Buy Rating on Akeso, Inc. (9926)
TipRanks · 06/06 09:05
More
About AKESF
Akeso Inc is an investment holding company dedicated to the research, development, manufacturing and commercialization of antibody drugs that are affordable to patients worldwide. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The Company's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.

Webull offers Akeso Inc stock information, including OTCPK: AKESF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKESF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKESF stock methods without spending real money on the virtual paper trading platform.